Acino Completes Takeda Deal In Emerging Markets
Covers UAE, Egypt, Saudi Arabia, Ukraine And South Africa
Executive Summary
Acino has completed its acquisition of parts of Takeda’s primary care portfolio in selected countries in the Middle East, Africa and Ukraine.
You may also be interested in...
Deal Watch: Lilly, AbCellera Partner To Attempt Rapid COVID-19 Antibody Development
Partnership will combine AbCellera’s screening of antibodies to the virus with Lilly’s development, commercial capabilities. Vir adds Biogen tie-up to its ongoing coronavirus efforts.
Acino Set To Begin Commercial Operations In Turkey
After registering itself as a legal entity in Turkey, Acino is set to begin commercial operations in the country this year.
Kelix Strikes A Deal To Acquire 14 Oncology Injectables
Kelix bio has announced two deals to expand its presence in Africa. The company is set to acquire 14 oncology injectable products from Germany-based Vitane. Furthermore, Kelix has acquired Pharmaceutical Institute, a pharmaceutical company established in Rabat, to enter Morocco. The pan-African company has also invested in Malta.